Differentiate your practice by adding an outcome-based solution for quality musculoskeletal care. Airrosti’s disciplined and measurable approach to care is what separates us from other groups in this space, providing an extremely portable and accountable solution for employers, carriers, and ACOs. We have a solid track record of partnering with recognized physicians, specialists, and health systems in the markets we serve. We have also demonstrated the ability to rehabilitate and resolve shoulder, back, knee, and other soft tissue injuries in a very short period of time through 3rd party episodic studies. The net result of all the claim episode studies to date confirms that Airrosti is lower in cost, results in shorter care duration, and has significantly lower post-care expenditure.
Our clinical pathways and treatment protocols are evidenced-based, in the strict definition, including staying up-to-date with and applying the latest clinical research and securing patient preference, outcomes, and feedback. For more clarification on the evaluation & treatment aspect, review the clinical guidelines for MSK injuries set forth by the Agency for Healthcare Research and Quality (AHRQ).
Each Airrosti visit is one full hour of dedicated one-on-one care with the patient. This time allows for a thorough clinical guidelines-based assessment, accurate diagnosis, highly specific manual therapy and active rehab. This approach will give your practice a competitive advantage in the marketplace and will become a first option for people in need of pain relief.
Unparalleled results and exceptional word-of-mouth help drive new patients to your office. Airrosti records outcomes from each and every patient case. Out of nearly 300,000 patient cases, 99.6% reported being satisfied or extremely satisfied following their Airrosti care. More than 6,700 patients reported Airrosti helped them avoid a recommended surgery. 88.8% reported complete injury resolution, and 94% reported significant improvement following their treatment. Conditions were completely resolved in an average of 3.2 visits.
Airrosti recognizes the importance of communicating pertinent information regarding your patients’ response to Airrosti treatment. Our providers are equipped to provide referring physicians with patient notes and information regarding your patient’s treatment progress, all patient-reported outcomes, any contraindications we may find, and any recommendations for imaging or referrals to a specialist. Patient management should always be a collaborative process, and we aim to be a key part of your specialist referral network if onsite collaboration is not an option.
Please contact us to learn more about Airrosti, to schedule a meeting with Airrosti personnel in your area, or to establish an expedited referral process.